Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The axes of access--improving care for patients with disabilities.
Brain Innate Immunity In The Regulation Of Neuroinflammation: Therapeutic Strategies By Modulating Cd200-Cd200r Interaction Involve The Cannabinoid System.
An analytical model for estimating water exchange rate in white matter using diffusion MRI.
Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis (SIMCOMBIN)
Treatment of Acute Disseminated Encephalomyelitis.
Trigger, pathogen, or bystander: the complex nexus linking Epstein- Barr virus and multiple sclerosis.
Glutamate gene polymorphisms predict brain volumes in multiple sclerosis.
Speech and pause characteristics in multiple sclerosis: A preliminary study of speakers with high and low neuropsychological test performance.
How can we exploit the brain's ability to repair itself?
Reverse causality behind the association between reproductive history and MS.
Minocycline Hydrochloride (1818)
Minocycline attenuates iron neurotoxicity in cortical cell cultures.
Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study.
A case of multiple sclerosis with pure, massive superficial demyelination.
Jekyll and Hide: The two faces of amyloid β.
Spatial variability and changes of metabolite concentrations in the cortico-spinal tract in multiple sclerosis using coronal CSI.
Sleep and oligodendrocyte functions.
Spatial modeling of multiple sclerosis for disease subtype prediction.
Urinary tract infections in multiple sclerosis: under-diagnosed and under-treated? A clinical audit at a large University Hospital.
Factors related to difficulties with employment in patients with multiple sclerosis: a review of 2002-2011 literature.
Rare Inflammatory Diseases of the White Matter and Mimics of Multiple Sclerosis and Related Disorders.
Viability of autoantibody-targets: How to tackle pathogenetic heterogeneity as an obstacle for treatment of multiple sclerosis.
Energy conservation for fatigue management in multiple sclerosis: a pilot randomized controlled trial.
Functional plasticity in MS: Friend or foe?
Self-efficacy and health status improve after a wellness program in persons with multiple sclerosis.

Pages